APA (7th ed.) Citation

T, S., S, L., A, B., MB, B., S, M., A, S., . . . F, R. (2026). Zirconium-89-based PSMA PET/CT with delayed imaging for early detection of biochemical recurrence in prostate cancer patients with PSA ≤ 0.2 ng/mL: A feasibility study. European journal of nuclear medicine and molecular imaging, 53(9), 5408. https://doi.org/10.1007/s00259-026-07854-x

Chicago Style (17th ed.) Citation

T, Speicher, et al. "Zirconium-89-based PSMA PET/CT with Delayed Imaging for Early Detection of Biochemical Recurrence in Prostate Cancer Patients with PSA ≤ 0.2 Ng/mL: A Feasibility Study." European Journal of Nuclear Medicine and Molecular Imaging 53, no. 9 (2026): 5408. https://doi.org/10.1007/s00259-026-07854-x.

MLA (9th ed.) Citation

T, Speicher, et al. "Zirconium-89-based PSMA PET/CT with Delayed Imaging for Early Detection of Biochemical Recurrence in Prostate Cancer Patients with PSA ≤ 0.2 Ng/mL: A Feasibility Study." European Journal of Nuclear Medicine and Molecular Imaging, vol. 53, no. 9, 2026, p. 5408, https://doi.org/10.1007/s00259-026-07854-x.